Any unsolicited idea or intellectual property submission made to the company automatically becomes company property, with no compensation to the submitter, no confidentiality obligation, and no restriction on the company's right to use, redistribute, or develop competing products based on the submission.
This analysis describes what UnitedHealthcare's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision asserts that unsolicited submissions transfer automatically to company ownership with no compensation or confidentiality obligation, and explicitly permits the company to develop competing products based on such submissions. The clause operates regardless of any contrary statements made in the submission itself.
Interpretive note: Enforceability of automatic assignment of submitted ideas as company property may depend on whether adequate prior notice of this policy was provided and may vary by jurisdiction.
Under this clause, any ideas or intellectual property submitted to the company outside of a formal agreement become company property automatically, with no duty of confidentiality and no compensation obligation. The agreement advises submitters to consult legal counsel before making submissions if they have intellectual property concerns.
Cross-platform context
See how other platforms handle Unsolicited Idea Submission Policy and similar clauses.
Compare across platforms →"If you still choose to make any submission to us, you agree as follows, regardless of any statements made in your submission that: We owe you no compensation; There is no duty of confidentiality between us and you; Your submission automatically becomes our property, and we may use or redistribute the contents of that submission in any way for any purpose; We are free to acquire, develop, and sell services and products that may be competitive to those you offer or suggest; and It is your responsibility to protect your own intellectual property; you should not make a submission to us if you have concerns about intellectual property.Excerpt from UnitedHealthcare's Terms of Use
(1) REGULATORY LANDSCAPE: This provision engages intellectual property law, including trade secret protection under the Defend Trade Secrets Act and applicable state trade secret statutes.
Enforcement risk, jurisdiction flags, contract triggers, and due diligence action items.
Get the weekly coverage letter
Companies change their terms without announcing it. We capture governance documents, compare each new version with the last, and publish what changed, with the source text behind it. One email a week on what we found and what we could not reach.
This provision asserts that unsolicited submissions transfer automatically to company ownership with no compensation or confidentiality obligation, and explicitly permits the company to develop competing products based on such submissions. The clause operates regardless of any contrary statements made in the submission itself.
Under this clause, any ideas or intellectual property submitted to the company outside of a formal agreement become company property automatically, with no duty of confidentiality and no compensation obligation. The agreement advises submitters to consult legal counsel before making submissions if they have intellectual property concerns.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by UnitedHealthcare.